Literature DB >> 2457256

Biologic response modifiers in the therapy of metastatic renal cell carcinoma.

J R Quesada1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457256

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  3 in total

Review 1.  Rationale for immunotherapy of renal cell carcinoma.

Authors:  R Heicappell; R Ackermann
Journal:  Urol Res       Date:  1990

2.  Enhanced in vivo cytotoxicity of recombinant human tumor necrosis factor with etoposide in human renal cell carcinoma. Evaluation in a pre-clinical model.

Authors:  J T Donaldson; T E Keane; S H Poulton; P J Walther
Journal:  Urol Res       Date:  1990

3.  Capecitabine in the treatment of metastatic renal cell carcinoma.

Authors:  K Oevermann; J Buer; R Hoffmann; A Franzke; A Schrader; T Patzelt; H Kirchner; J Atzpodien
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.